コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ion of trigeminal inputs in diseases such as hemifacial spasm.
2 rs that affect one side of the face, such as hemifacial spasm.
3 nonsurgical treatment for blepharospasm and hemifacial spasm.
4 he eyelid for treatment of blepharospasm and hemifacial spasm.
5 t option for patients with blepharospasm and hemifacial spasm.
6 not been well characterized in patients with hemifacial spasm.
7 ted to the symptomatic side in patients with hemifacial spasm.
8 ghly associated with the symptomatic side in hemifacial spasm.
9 , 70.4 [9.1] years); of the 56 patients with hemifacial spasm, 25 (44.6%) used alleviating maneuvers
14 ients with benign essential blepharospasm or hemifacial spasm are known to use botulinum toxin inject
15 euvers for benign essential blepharospasm or hemifacial spasm correlates with disease severity or bot
16 viating maneuvers used for blepharospasm and hemifacial spasm, dystonia severity, and dose and freque
17 s [95% CI, -10 to 70 units]; P = .15) or the hemifacial spasm group (58 vs 60 units; Hodges-Lehmann m
18 dy period, excluding those with a history of hemifacial spasm (HFS), facial palsy, traumatic brain in
20 nfants with similar semiology (described as "hemifacial spasm"), imaging findings, and histopathology
22 jection visits required by blepharospasm and hemifacial spasm patients during their course of treatme
23 iating maneuvers scored higher on the 7-item Hemifacial Spasm Quality of Life scale (median score, 7
25 ee disorders (strabismus, blepharospasm, and hemifacial spasm), the number of indications being treat
28 0 [95% CI, 0-1]; P = .03) than patients with hemifacial spasm who did not use alleviating maneuver.
30 essential blepharospasm and 56 patients with hemifacial spasm who were consecutively recruited from a